Adaptin Bio (APTN) Invested Capital (2022 - 2026)

Adaptin Bio has disclosed Invested Capital across 5 years of filings, most recently posting -$1.5 million for Q1 2026.

• Quarterly Invested Capital fell 187.95% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 million (down 187.95% YoY) and the FY2025 annual result came in at -$1.5 million, up 58.11% from the prior year.
• Invested Capital declined to -$1.5 million in Q1 2026, from -$1.5 million in the prior quarter.
• Across five years, Invested Capital topped out at $1.7 million in Q1 2025 and bottomed at -$3.6 million in Q4 2024.
• The 5-year median for Invested Capital is -$929318.5 (2023), against an average of -$934842.6.
• Year-over-year, Invested Capital plunged 5865.06% in 2024 and surged 232.52% in 2025.
• Adaptin Bio's Invested Capital stood at -$27304.0 in 2022, then tumbled by 3480.28% to -$977559.0 in 2023, then slumped by 263.68% to -$3.6 million in 2024, then soared by 58.11% to -$1.5 million in 2025, then dropped by 3.05% to -$1.5 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered -$1.5 million, -$1.5 million, and -$881078.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.